NEI Research News

A study of a gateway receptor for SARS-CoV-2 from Louisiana State University may help explain the wide variety of symptoms and organs involved with SARS-CoV-2 infection and COVID-19.

Targeting specific areas of the measles virus polymerase, a protein complex that copies the viral genome, can effectively fight the measles virus and be used as an approach to developing new antiviral drugs to treat the serious infectious disease...

Researchers evaluated motor skills and cognitive development, visual and hearing function, and brain images of children who had been exposed to the Zika virus during their mothers' pregnancies. 14.5 percent of children had at least one abnormality.

NEI funded researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that trigger inflammation during–and even after–a herpes virus infection. Their results are published in the journal Cell Reports.

A new study funded in part by NEI and published in Nature Communications reveals a mechanism involved in the regulation of a process called lymphangiogenesis, specifically in corneal transplants and infectious eye disease.

Following the 2014 Ebola outbreak in West Africa that took the lives of more than 11,200 people in the region, the National Eye Institute, part of the National Institutes of Health, has deployed a team of clinicians and technical experts to Monrovia...

Children who sleep in unventilated rooms with cooking fires are at greater risk for severe trachoma, a leading cause of preventable blindness in developing countries.

The Liberia-U.S. clinical research partnership known as PREVAIL has launched a study of people in Liberia who have survived Ebola virus disease (EVD) within the past two years.

Patients with acquired immunodeficiency syndrome (AIDS) have a four-fold increase in their risk of developing intermediate-stage age-related macular degeneration (AMD) compared to people of the same age who are not infected with HIV.

A clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), has concluded that a single dose of azithromycin taken by mouth after surgery reduces by one-third the recurrence of a vision-threatening...